Delivery Order SPE2DR25D3103-SPE2DR26F9V39
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,758.82 to AmerisourceBergen Drug Corp for Leuprolide 2-week 14 mg/2.8 ml kits on December 10, 2025, with an ultimate completion date of December 11, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Leuprolide 2-week 14 mg/2.8 mL kits with a firm fixed price ceiling value of $39,070.90. This is a non-set-aside, competitively awarded delivery order to be performed at the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $34,905.96 to AmerisourceBergen Drug Corp for the supply of Leuprolide 2-week 14 mg/2.8 ml kits, with an ultimate completion date of November 6, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Lupron Depot-AD 1S, a leuprolide acetate product used in hormone treatment therapies. This firm fixed-price delivery order has a ceiling value of $44,772.88 and is scheduled for completion by January 13, 2026. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LEUPROLIDE 2WK 14 MG/2.8 ML KTS, a specialty medication, with a ceiling value of $3,570.36 and a period of performance through February 25, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,869.12 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of leuprolide, a specialty injectable medication, to support military treatment programs and facilities. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,423,235 units of the pharmaceutical product LEUPROLIDE 2WK 14 MG/2.8 ML KTS. The delivery order, which has a potential value of $23,373.98, was issued without any set-aside designation and has a completion date of January 25, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has...
- The Defense Logistics Agency awarded a $3,242 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 14 mg/2.8 ml kits of Leuprolide, a gonadotropin-releasing hormone agonist. Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania under the terms of the order, which runs from July 10-11, 2023. As a division of Amerisourcebergen Corporation, the prime contractor will utilize its extensive...
- The Defense Logistics Agency Troop Support Medical awarded a $485,840 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561830844 LEUPROLIDE 2WK 14 MG/2.8 ML KITS. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is from August 16, 2023 through August 17, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $89,527.69 on September 19, 2025, for a kit of Lupron Depot-AD 1S, a hormone treatment medication. The contract is a firm fixed-price delivery order with an ultimate completion date of October 17, 2025, and carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9V39Delivery Order
On January 7, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $34,000 to AmerisourceBergen Drug Corp for the supply of Leuprolide 2-week 14 mg/2.8 ml kits. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 8, 2026, and represents a competitively awarded, non-set-aside procurement. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply vehicle valued through December 31, 2031. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a diverse portfolio of brand-name and generic medications across multiple therapeutic domains. The leuprolide products being delivered under this order support hormone-related medical treatments within the military healthcare supply chain. AmerisourceBergen's role as a prime vendor through the DLA's pharmaceutical distribution network enables efficient fulfillment of essential medical commodities to military treatment facilities and other federal healthcare institutions, with the firm fixed-price structure ensuring cost predictability for government medical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 1/6/26 |